BrainQuant appears positioned to fill a specific gap in the dementia diagnostics pipeline by offering a software-only ASL-MRI analysis layer that approximates PET-level perfusion data without radioactive tracers. As a freshly launched Wyss Center spin-off with no external funding round, it sits at the earliest stage of commercial translation in a competitive AI neuroimaging field.